{"pmid":32239514,"title":"Comments on Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China.","text":["Comments on Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China.","We have read the article by Zhang et al. published in the recent issue of the Journal of Medical Virology(1) . Zhang and his colleagues have made a cross-sectional survey of currently registered clinical trials concerning 2019-nCoV, including the published literature. As such, they have given a preliminary assessment on the prospects of therapy for 2019-nCoV. This article is protected by copyright. All rights reserved.","J Med Virol","Yu, Yang","Shi, Qianling","Chen, Hao","32239514"],"abstract":["We have read the article by Zhang et al. published in the recent issue of the Journal of Medical Virology(1) . Zhang and his colleagues have made a cross-sectional survey of currently registered clinical trials concerning 2019-nCoV, including the published literature. As such, they have given a preliminary assessment on the prospects of therapy for 2019-nCoV. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yu, Yang","Shi, Qianling","Chen, Hao"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239514","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25806","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1662996001857732608,"score":7.6048946,"similar":[{"pmid":32232977,"title":"Response to \"Comments on 'Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China '\".","text":["Response to \"Comments on 'Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China '\".","We thank Dr. Yang and colleagues for their attention to our article(1,2) . And we appreciate their meaningful suggestions, which we highly agree with. With the purpose of letting the public know the overall situation of the clinical trials of new coronary pneumonia in China as soon as possible, we completed the data collection and brief analysis in a very short time. This article is protected by copyright. All rights reserved.","J Med Virol","Zhang, Qi","Wang, Yakun","Qi, Changsong","Shen, Lin","Li, Jian","32232977"],"abstract":["We thank Dr. Yang and colleagues for their attention to our article(1,2) . And we appreciate their meaningful suggestions, which we highly agree with. With the purpose of letting the public know the overall situation of the clinical trials of new coronary pneumonia in China as soon as possible, we completed the data collection and brief analysis in a very short time. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zhang, Qi","Wang, Yakun","Qi, Changsong","Shen, Lin","Li, Jian"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232977","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25803","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1662899337781313537,"score":252.8065},{"pmid":32239515,"title":"Fecal Transmission in COVID-19: A Potential Shedding Rout.","text":["Fecal Transmission in COVID-19: A Potential Shedding Rout.","We read with interest recent article by Zhang et al (1) on the diagnosis of Coronavirus disease 2019 (COVID-19) by fecal specimen test. Following the recent outbreak of pneumonia with unknown pathogen in Hubei province in China, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from human airway epithelial cells and the disease was named COVID-19.(2) It is a public health emergency of international concern and rapidly spearing all over the world.(3) This article is protected by copyright. All rights reserved.","J Med Virol","Nouri-Vaskeh, Masoud","Alizadeh, Leila","32239515"],"abstract":["We read with interest recent article by Zhang et al (1) on the diagnosis of Coronavirus disease 2019 (COVID-19) by fecal specimen test. Following the recent outbreak of pneumonia with unknown pathogen in Hubei province in China, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from human airway epithelial cells and the disease was named COVID-19.(2) It is a public health emergency of international concern and rapidly spearing all over the world.(3) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Nouri-Vaskeh, Masoud","Alizadeh, Leila"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239515","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25816","source":"PubMed","locations":["China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1662996001622851584,"score":189.83234},{"pmid":32239511,"title":"Sore throat in COVID-19: comment on \"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis\".","text":["Sore throat in COVID-19: comment on \"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis\".","We read with interest the recent meta-analysis by Sun et al.(1) that included 50466 patients with Coronavirus Disease 2019 (COVID-19). The author found that fever and cough were the most common symptoms, and several subjects had muscle soreness or fatigue. In addition, they reported that \"by reading the included literature, we found that diarrhea, hemoptysis, headache, sore throat, shock, and other symptoms are rare\".(1) This article is protected by copyright. All rights reserved.","J Med Virol","Lovato, Andrea","Rossettini, Giacomo","de Filippis, Cosimo","32239511"],"abstract":["We read with interest the recent meta-analysis by Sun et al.(1) that included 50466 patients with Coronavirus Disease 2019 (COVID-19). The author found that fever and cough were the most common symptoms, and several subjects had muscle soreness or fatigue. In addition, they reported that \"by reading the included literature, we found that diarrhea, hemoptysis, headache, sore throat, shock, and other symptoms are rare\".(1) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lovato, Andrea","Rossettini, Giacomo","de Filippis, Cosimo"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239511","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25815","source":"PubMed","weight":0,"_version_":1662996001720369152,"score":133.9345},{"pmid":32227489,"title":"Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.","text":["Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.","I read with interest the meta-analysis of patient clinical characteristics and fatality rates in COVID-19 from Chinese samples by Li and colleagues(1) . I was surprised by the fatality rate of 7% which is much than higher than the value of 1.4% reported in a large study of Chinese patients by Guan et al (2020)(2) . This article is protected by copyright. All rights reserved.","J Med Virol","Kempton, Matthew","32227489"],"abstract":["I read with interest the meta-analysis of patient clinical characteristics and fatality rates in COVID-19 from Chinese samples by Li and colleagues(1) . I was surprised by the fatality rate of 7% which is much than higher than the value of 1.4% reported in a large study of Chinese patients by Guan et al (2020)(2) . This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Kempton, Matthew"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227489","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25799","source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1662819280328065024,"score":131.20703},{"pmid":32243596,"title":"Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19.","text":["Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19.","We have read with interest the paper by Li and colleagues about the neurotropism of the severe acute respiratory syndrome coronavirus (SARS-CoV-2), responsible of coronavirus disease (COVID-19), recently discovered in China and now worldwide spread.(1) In particular, the paper focuses on the role of the nervous system involvement in causing the respiratory failure. This article is protected by copyright. All rights reserved.","J Med Virol","Coraci, Daniele","Fusco, Augusto","Frizziero, Antonio","Giovannini, Silvia","Biscotti, Lorenzo","Padua, Luca","32243596"],"abstract":["We have read with interest the paper by Li and colleagues about the neurotropism of the severe acute respiratory syndrome coronavirus (SARS-CoV-2), responsible of coronavirus disease (COVID-19), recently discovered in China and now worldwide spread.(1) In particular, the paper focuses on the role of the nervous system involvement in causing the respiratory failure. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Coraci, Daniele","Fusco, Augusto","Frizziero, Antonio","Giovannini, Silvia","Biscotti, Lorenzo","Padua, Luca"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243596","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25829","keywords":["Coronavirus","Nervous system","Public policy"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1663079112813576193,"score":123.88559}]}